The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Cardiff University · Midatech Pharma (United Kingdom) · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,118
total citations
- FWCI
- 53.78
- Percentile
- 100%
- References
- 24
Citations per year
Authors
3Topics & keywords
Keywords
- Metformin
- Medicine
- Insulin glargine
- Insulin
- Internal medicine
- Sulfonylurea
- Type 2 diabetes
- Endocrinology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.